March 29 2017, JRSIS HEALTH CARE CORPORATION（JRSS）, a full medical service hospital group serving in Harbin City of Heilongjiang, announced financial year for the ended December 31, 2016.
“JHCC had another strong performance this year with revenue increased 53% than last year, the total revenue was $18.12 Million,“Said Xuewei Zhang, CFO of JRSS. “We continue to be excited about the growth in our healthcare businesses.”
JRSIS HEALTH CARE CORPORATION reported consolidated revenues of $18,12 million for the year ended Dcember 31, 2016 an increase of 53% compared to the year of 2015. The increase was primarily as result of the number of treated inpatients growing to 14,276 patients, 4,036 more than the 10,240 patients treated in the year ended December 31, 2015.
For the year ended December 31, 2016, Net income was $5.02 million, an increase of $2.38 million or 90% compared to the same period of 2015. EBITDA was $7.49 million, an increase of 58% compared to the same period of 2015. For the year ended December 31, 2016 and 2015 total operating costs and expenses was $13.10 million and $9.24 million,respectively.
Revenues-JRSS had another strong performance this year, with revenue increased 53% compared to the same period of 2015, was $18.12 million.
Property and equipment-JRSS purchased $3.42 million worth equipment for the hospital for the year of 2016.
This press release includes certain statements that may be deemed to be “forward-looking statements” within the meaning of Section 27 A of the Securities Act of 1933, as amended, and Section 21 E of the Securities Exchange Act of 1934, as amended. All statements included in this press release, other than statements of historical facts, address matters that JRSIS HEALTH CARE CORPORATION (“the company“or“JRSS”) reasonably expects, believes or anticipates will or may occur in the future. These statements are made on the basis of management‘s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. Such statements are subject to various as sumptions, risks and uncertainties. In vestors are cautioned that any such statements are not guarantees of future performance and that actual results or developments may differ materially as those discussed in the JHCC‘s reports filed with the Securities and Exchange Commission from time to time.
More information about JRSS: